ArticleClinical ophthalmology (Auckland, N.Z.)2013

Six-month results from a Phase III randomized trial of fixed-combination brinzolamide 1% + brimonidine 0.2% versus brinzolamide or brimonidine monotherapy in glaucoma or ocular hypertension.

Jess T Whitson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.